Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers

Estrogen receptor-α positive (ERα+) breast cancer accounts for approximately 70–80% of the nearly 25,0000 new cases of breast cancer diagnosed in the US each year. Endocrine-targeted therapies (those that block ERα activity) serve as the first line of treatment in most cases. Despite the proven bene...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cell Death Dis
Päätekijät: Williams, Michelle M., Lee, Linus, Werfel, Thomas, Joly, Meghan M. Morrison, Hicks, Donna J., Rahman, Bushra, Elion, David, McKernan, Courtney, Sanchez, Violeta, Estrada, Monica V., Massarweh, Suleiman, Elledge, Richard, Duvall, Craig, Cook, Rebecca S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833697/
https://ncbi.nlm.nih.gov/pubmed/29343814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0072-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia